References Associated with Literature Topic: Biofilms





Reference SpeciesGenes Addressed
Basrani S, et al. (2025) Repurposing of quinine as an antifungal antibiotic: Identification of molecular targets in Candida albicans. Folia Microbiol (Praha)
CGD Papers Entry Pubmed Entry
C. albicans |ALS1 |CAP1 |CAT1 |KRE9 |MCA1 |SOD1 |SOD2
Bila NM, et al. (2025) Trichophyton rubrum inhibits Candida albicans filamentation and its gene expression when grown in biofilms in vitro. Mem Inst Oswaldo Cruz 120:e240221
CGD Papers Entry Pubmed Entry
C. albicans |CPH1 |EFG1 |HWP1
Buonanno A, et al. (2025) The Biotherapeutic Potential of a Novel Probiotic Kluyveromyces marxianus Isolated from a Sourdough Starter Against Vaginal Candida albicans Strains. J Fungi (Basel) 11(2)
CGD Papers Entry Pubmed Entry
C. albicans |SAP2 |SAP6
Chavez JF, et al. (2025) Virulence Factors and Molecular Identification of Candida Species Causing Candidemia in Honduras. J Fungi (Basel) 11(7)
CGD Papers Entry Pubmed Entry
C. albicans |ITS1 |ITS2
Chougule S, et al. (2025) Alpha-bisabolol inhibits yeast to hyphal form transition and biofilm development in Candida albicans: in vitro and in silico studies. In Silico Pharmacol 13(1):53
CGD Papers Entry Pubmed Entry
C. albicans |CST20 |RAS1 |TUP1
Consuegra-Asprilla JM, et al. (2025) Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes. Mycoses 68(2):e70031
CGD Papers Entry Pubmed Entry
C. albicans |PRA1
Costa TL, et al. (2025) Preventing Oral Dual Biofilm Development with Innovative Bioactive Varnishes. J Funct Biomater 16(2)
CGD Papers Entry Pubmed Entry
Czucz Varga J, et al. (2025) Mixed Candida albicans-Staphylococcus aureus Biofilm Is Reduced by Light-Activated Nanocomposite with Phloxine B. J Fungi (Basel) 11(8)
CGD Papers Entry Pubmed Entry
C. albicans |ALS3 |HWP1
Dias LM, et al. (2025) Unlocking Histatin Potential against Candida albicans and Streptococcus mutans Biofilms: Targeting the Extracellular Matrix While Preserving Oral Cell Integrity. ACS Omega 10(25):27011-27022
CGD Papers Entry Pubmed Entry
El Hady R, et al. (2025) Phenotypic and genotypic characterization of Candida parapsilosis complex isolates from a Lebanese hospital. Sci Rep 15(1):4853
CGD Papers Entry Pubmed Entry
C. parapsilosis |ALS6 |ALS7 |CDR1 |ERG11 |ERG6 |SAP7 |SAP9 |SAPP3 |UPC2
Eshimy R, et al. (2025) A novel clotrimazole selenium nano-composite for combating deep dermal Candida albicans infections and virulence genes. J Antibiot (Tokyo)
CGD Papers Entry Pubmed Entry
C. albicans |ALS1 |CDR1 |ERG11 |PLB1
Fayed B, et al. (2025) Comparative evaluation of biologically and chemically synthesized zinc oxide nanoparticles for preventing Candida auris biofilm. Biometals
CGD Papers Entry Pubmed Entry
C. auris |ALS5 |CDR1 |CSA1 |ERG11 |ERG2 |FKS1 |IFF4 |MDR1
Fleres G, et al. (2025) Blood cultures contain populations of genetically diverse Candida albicans strains that may differ in echinocandin tolerance and fitness. J Infect Dis
CGD Papers Entry Pubmed Entry
C. albicans |NRG1
Guo YD, et al. (2025) Hyssopus cuspidatus Boriss Volatile Extract (SXC): A Dual-Action Antioxidant and Antifungal Agent Targeting Candida albicans Pathogenicity and Vulvovaginal Candidiasis via Host Oxidative Stress Modulation and Fungal Metabolic Reprogramming. Antioxidants (Basel) 14(9)
CGD Papers Entry Pubmed Entry
C. albicans |ALS3 |CYR1 |ECE1 |EFG1 |HWP1 |PDE2 |RAS1 |TUP1 |UME6
Jia H, et al. (2025) Discovery of novel azole derivatives with benzanilide-containing hydrophobic side chains for the treatment of drug-resistant fungal infections. RSC Adv 15(13):10170-10182
CGD Papers Entry Pubmed Entry
C. albicans |CDR1 |ERG11
Jiang L, et al. (2025) Triazine amine compounds synergistically enhance the efficacy against fluconazole-resistant Candida albicans with fluconazole by inhibiting cell wall synthesis. Biochem Pharmacol 241:117181
CGD Papers Entry Pubmed Entry
C. albicans |CHS1 |CHS8 |GSC1 |GSL1 |HOG1 |WSC1 |WSC2
Jin HW and Eom YB (2025) Potent anti-biofilm properties of plumbagin against fluconazole-resistant Candida auris. J Tradit Complement Med 15(2):140-146
CGD Papers Entry Pubmed Entry
C. auris |CDR1 |ERG11 |KRE6
Jothi R, et al. (2025) Lupeol mitigates biofilm formation and attenuates virulence dimorphism in Candida albicans. Microb Pathog 208:107989
CGD Papers Entry Pubmed Entry
C. albicans |CPH1 |EFG1 |HWP1 |RAS1 |TUP1 |UME6
Karami-Feli M, et al. (2025) Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights. Iran Biomed J
CGD Papers Entry Pubmed Entry
C. albicans |ERG11 |HWP1 |SAP1 |SAP2
Kim YG, et al. (2025) Targeting biofilm formation in Candida albicans with halogenated pyrrolopyrimidine derivatives. Eur J Med Chem 290:117528
CGD Papers Entry Pubmed Entry
C. albicans |ALS3 |CDR11 |CSR1 |ECE1 |GST3 |HWP1 |IFD1 |IFD6 |UCF1 |UME6 |YWP1
Kumar AC, et al. (2025) Targeting fungal biofilms: design, synthesis, biological and in silico studies of novel N-(5-undecyl-1,3,4-oxadiazol-2-yl)benzamide derivatives against Candida albicans. Bioorg Med Chem 131:118425
CGD Papers Entry Pubmed Entry
C. albicans |ALS1 |ALS3 |EFG1 |HWP1
Lee S, et al. (2025) Candida albicans biofilm extracellular vesicles deliver candidalysin to epithelial cell membranes and induce host cell responses. Infect Immun 93(5):e0040424
CGD Papers Entry Pubmed Entry
C. albicans |ECE1
Li Y, et al. (2025) In vitro evaluation of tolerance ability of cross-kingdom biofilm towards oral dynamic fluctuations. BMC Oral Health 25(1):1216
CGD Papers Entry Pubmed Entry
C. albicans |ALS1 |ALS3 |CAT1 |HWP1 |SOD1 |TRX1
Liang T, et al. (2025) Discovery of New Pyrazolone Carbothioamide Derivatives as Potent Antifungal Agents for the Treatment of Candidiasis and Cryptococcosis. J Med Chem
CGD Papers Entry Pubmed Entry
C. albicans |CAT1 |GPX1 |SOD1 |TRR1 |TRX1 |TSA1
C. glabrata |PDR1
Liu Y, et al. (2025) Activity of 6-methoxydihydrosanguinarine from Hylomecon japonica against wild-type and fluconazole-resistant Candida albicans biofilms. J Asian Nat Prod Res :1-12
CGD Papers Entry Pubmed Entry
C. albicans |CYR1 |EFG1 |RAS1 |TPK2
Mendonca Dias L, et al. (2025) Salivary Proteins-Enhanced Antimicrobial Photodynamic Therapy: Overcoming Three Distinct Cultures of Resistant Mixed Biofilms. J Dent :105778
CGD Papers Entry Pubmed Entry
Mezni G, et al. (2025) New Curcumin Analogue (PAC) Inhibits Candida albicans Virulence, Restricts Its Adhesion Potential, and Relieves Oral Epithelial Cell Inflammation and Defense Mechanisms. Antibiotics (Basel) 14(5)
CGD Papers Entry Pubmed Entry
C. albicans |EAP1 |HWP1 |SAP1 |SAP2 |SAP3 |SAP4 |SAP5 |SAP6 |SAP7 |SAP8 |SAP9
Mishra AP, et al. (2025) Characterization and enhanced antibiofilm activity of Annona muricata extract in combination with fluconazole against Candida albicans. Drug Target Insights 19:1-10
CGD Papers Entry Pubmed Entry
C. albicans |SAP3
Nikoomanesh F, et al. (2025) Exploring the Antifungal Potential of Lawsone-Loaded Mesoporous Silica Nanoparticles Against Candida albicans and Candida glabrata: Growth Inhibition and Biofilm Disruption. J Fungi (Basel) 11(6)
CGD Papers Entry Pubmed Entry
C. glabrata |EPA1
C. albicans |ALS1
Nouraei H, et al. (2025) Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis. Sci Rep 15(1):31292
CGD Papers Entry Pubmed Entry
C. albicans |ALS1 |ALS3 |CDR1 |CDR2 |MDR1
Result Page : 1 2 3 4 5 6 7 8 9 10 Next




AltStyle によって変換されたページ (->オリジナル) /